PMC:7594251 / 1633-1729
Annnotations
{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7594251","sourcedb":"PMC","sourceid":"7594251","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7594251","text":"We also summarize the advantages and limitations of the primary NMR methods in drug development.","tracks":[{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T11","span":{"begin":79,"end":83},"obj":"Chemical"}],"attributes":[{"id":"A11","pred":"chebi_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"subj":"T11","pred":"source","obj":"LitCovid-PD-CHEBI"}]},{"project":"LitCovid-sentences","denotations":[{"id":"T15","span":{"begin":0,"end":96},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T15","pred":"source","obj":"LitCovid-sentences"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PD-CHEBI","color":"#bcec93","default":true},{"id":"LitCovid-sentences","color":"#ec93d6"}]}]}}